Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat

Neuropsychopharmacology

Volumn 26, Issue 5, 2002, Pages 583-594

  Shirazi Southall, Sudabeh ^a   Rodriguez, Dana Ellen ^a   Nomikos, George G ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Acetylcholine; Antipsychotic; Clozapine; Microdialysis; Olanzapine; Schizophrenia

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 AMINO N [2,6 BIS(METHYLAMINO) 4 PYRIMIDINYL]BENZENESULFONAMIDE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; ACETYLCHOLINE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHLORPROMAZINE; CLOZAPINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PRAZOSIN; RACLOPRIDE; RISPERIDONE; SEROTONIN 1A AGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2C ANTAGONIST; SEROTONIN 6 RECEPTOR; THIORIDAZINE; YOHIMBINE; ZIPRASIDONE;

ACETYLCHOLINE BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COGNITION; CONTROLLED STUDY; DRUG EFFECT; DRUG SELECTIVITY; HIPPOCAMPUS; HORMONE TRANSPORT; MALE; MICRODIALYSIS; MONOAMINERGIC SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

ACETYLCHOLINE; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CHLORPROMAZINE; CLOZAPINE; DIALYSIS SOLUTIONS; DOPAMINE ANTAGONISTS; EXTRACELLULAR SPACE; HALOPERIDOL; HIPPOCAMPUS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; MALE; MICRODIALYSIS; PIPERAZINES; PIRENZEPINE; RATS; RATS, WISTAR; RISPERIDONE; SEROTONIN ANTAGONISTS; THIAZOLES; THIORIDAZINE;

EID: 0036201186     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(01)00400-6     Document Type: Article

References (59)

1. Dopaminergic regulation of striatal acetylcholine release: The critical role of acetylcholinesterase inhibition
2. Pharmacology of sensory stimulation-evoked increases in frontal cortical acetylcholine release
3. Prazosin modulates the changes in firing pattern and transmitter release induced by raclopride in the mesolimbic, but not in the nigrostriatal dopaminergic system
4. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system
5. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence
6. Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats
7. Identification of the primary muscarinic autoreceptor subtype in rat striatum as M2 through a correlation of in vivo microdialysis and in vitro receptor binding data
8. Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells
9. Cognitive deficit in schizophrenia and its neurochemical basis
10. Radioreceptor binding profile of the atypical antipsychotic olanzapine
11. Olanzapine: A basic science update
12. Decreased binding affinity of olanzapine and clozapine for human muscarinic receptors in intact clonal cells in physiological medium
13. Olanzapine belongs to a new multi-acting-receptor-targeted-antipsychotic (MARTA) class of antipsychotics
14. In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: Implications for drug mechanisms of action
15. Endogenous serotonin facilitates in vivo acetylcholine release in rat frontal cortex through 5-HT 1B receptors
16. Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: A longitudinal study
17. Cholinergic activity in the rat hippocampus, cortex and striatum correlates with locomotor activity: An in vivo microdialysis study
18. Physiological release of striatal acetylcholine in vivo: Modulation by D1 and D2 dopamine receptor subtypes
19. The hippocampus, memory, and place cells: Is it spatial memory or a memory space?
20. Studies to investigate the role of 5-HT(2C) receptors on cocaine-and food-maintained behavior
21. Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade
22. The antipsychotic drug risperidone interacts with auto- and hetero receptors regulating serotonin output in the rat frontal cortex
23. Effects of local cholinesterase inhibition on acetylcholine release assessed simultaneously in prefrontal and frontoparietal cortex
24. Serotonergic regulation of acetylcholine release in rat frontal cortex
25. Relations between the extracellular concentrations of choline and acetylcholine in rat striatum
26. Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors
27. Hippocampal serotonin 5- HT1A receptor enhances acetylcholine release in conscious rats
28. Determination of acetylcholine release in the striatum of anesthetized rats using in vivo microdialysis and a radioimmunoassay
29. Mechanisms of action of atypical antipsychotic drugs: A critical analysis
30. In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone
31. Effects of atypical antipsychotic drugs on dopamine output in the shell and core of the nucleus accumbens: Role of 5-HT(2A) and alpha(1)-adrenoceptor antagonism
32. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values
33. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia
34. Cholinesterase inhibitor effects on extracellular acetylcholine in rat striatum
35. Muscarinic receptors mediate attenuation of extracellular acetylcholine levels in rat cerebral cortex after cholinesterase inhibition
36. Effects of neostigmine and atropine on basal and handling-induced acetylcholine output from ventral hippocampus
37. Role of accumbens and cortical dopamine receptors in the regulation of cortical acetylcholine release
38. Effects of oxotremorine and pilocarpine on striatal acetylcholine release as studied by brain dialysis in anesthetized rats
39. The novel 5-HT1A receptor antagonist (S)-UH-301 prevents (R)-8-OH-DPAT-induced decrease in interstitial concentrations of serotonin in the rat hippocampus
40. Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex
41. Effects of a M1 muscarinic receptor agonist on the central cholinergic system, evaluated by brain microdialysis
42. Selective action of acute systemic clozapine on acetylcholine release in the rat prefrontal cortex by reference to the nucleus accumbens and striatum
43. Measuring neuropsychological change in schizophrenia with novel antipsychotic medications
44. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol
45. Muscarinic and nicotinic modulation of cortical acetylcholine release monitored by in vivo microdialysis in freely moving adult rats
46. Atypical antipsychotics: Are some more atypical than others?
47. Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation
48. 5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex
49. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors
50. Neuroleptics increase striatal acetylcholine release by a sequential D-1 and D-2 receptor mechanism
51. Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding
52. Effects of M2 antagonists on in vivo hippocampal acetylcholine levels
53. Characterization of the neurochemical effects of N-[2-(1-azabicyclo[3,3,0]octan-5-yl)ethyl]2-nitroaniline fumarate (SK-946) as a cognition activator
54. Acetylcholine release in the rat prefrontal cortex in vivo: Modulation by alpha 2-adrenoceptor agonists and antagonists
55. L-DOPA inhibits spontaneous acetylcholine release from the striatum of experimental Parkinson's model rats
56. 5-HT1A receptor activation increases hippocampal acetylcholine efflux and motor activity in the guinea pig: Agonist efficacy influences functional activity in vivo
57. The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1,D2,D3,5HT2A and muscarinic receptors
58. Systemic chlorophenylpiperazine increases acetylcholine release from rat hippocampus-implication of 5-HT2C receptors